Baxter Operating Expenses 2010-2024 | BAX

Baxter annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Baxter operating expenses for the quarter ending June 30, 2024 were $4.004B, a 7.52% increase year-over-year.
  • Baxter operating expenses for the twelve months ending June 30, 2024 were $14.724B, a 13.3% decline year-over-year.
  • Baxter annual operating expenses for 2023 were $14.423B, a 13.89% decline from 2022.
  • Baxter annual operating expenses for 2022 were $16.749B, a 55.14% increase from 2021.
  • Baxter annual operating expenses for 2021 were $10.796B, a 7.35% increase from 2020.
Baxter Annual Operating Expenses
(Millions of US $)
2023 $14,423
2022 $16,749
2021 $10,796
2020 $10,057
2019 $9,590
2018 $9,515
2017 $9,296
2016 $9,418
2015 $9,519
2014 $10,063
2013 $8,917
2012 $11,166
2011 $10,947
2010 $10,707
2009 $9,685
Baxter Quarterly Operating Expenses
(Millions of US $)
2024-06-30 $4,004
2024-03-31 $3,405
2023-12-31 $3,556
2023-09-30 $3,759
2023-06-30 $3,724
2023-03-31 $3,384
2022-12-31 $3,386
2022-09-30 $6,489
2022-06-30 $3,330
2022-03-31 $3,544
2021-12-31 $2,853
2021-09-30 $2,713
2021-06-30 $2,674
2021-03-31 $2,556
2020-12-31 $2,775
2020-09-30 $2,502
2020-06-30 $2,387
2020-03-31 $2,393
2019-12-31 $2,503
2019-09-30 $2,348
2019-06-30 $2,484
2019-03-31 $2,255
2018-12-31 $2,433
2018-09-30 $2,379
2018-06-30 $2,458
2018-03-31 $2,245
2017-12-31 $2,509
2017-09-30 $2,407
2017-06-30 $2,258
2017-03-31 $2,122
2016-12-31 $2,342
2016-09-30 $2,372
2016-06-30 $2,517
2016-03-31 $2,187
2015-12-31 $2,425
2015-09-30 $2,395
2015-06-30 $2,388
2015-03-31 $2,311
2014-12-31 $2,598
2014-09-30 $2,492
2014-06-30 $3,495
2014-03-31 $3,176
2013-12-31 $3,776
2013-09-30 $3,056
2013-06-30 $2,841
2013-03-31 $2,733
2012-12-31 $2,976
2012-09-30 $2,700
2012-06-30 $2,795
2012-03-31 $2,695
2011-12-31 $2,969
2011-09-30 $2,734
2011-06-30 $2,705
2011-03-31 $2,539
2010-12-31 $2,975
2010-09-30 $2,442
2010-06-30 $2,496
2010-03-31 $2,794
2009-12-31 $2,737
2009-09-30 $2,413
2009-06-30 $2,376
2009-03-31 $2,159
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.673B $14.813B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $202.220B 25.79
Stryker (SYK) United States $143.322B 32.30
Boston Scientific (BSX) United States $130.065B 37.39
Medtronic (MDT) Ireland $112.498B 16.74
EssilorLuxottica (ESLOY) France $111.686B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.423B 0.00
Haleon (HLN) United Kingdom $43.501B 28.26
GE HealthCare Technologies (GEHC) United States $39.264B 20.36
ResMed (RMD) United States $37.048B 30.44
Terumo (TRUMY) Japan $29.575B 41.77
Koninklijke Philips (PHG) Netherlands $25.012B 19.14
Zimmer Biomet Holdings (ZBH) United States $21.536B 13.71
Insulet (PODD) United States $18.791B 74.86
Smith & Nephew SNATS (SNN) United Kingdom $10.619B 0.00
Bio-Rad Laboratories (BIO) United States $10.338B 35.13
BellRing Brands (BRBR) United States $9.136B 38.63
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $6.084B 14.14
Haemonetics (HAE) United States $4.474B 21.43
TG Therapeutics (TGTX) United States $4.460B 0.00
ICU Medical (ICUI) United States $4.318B 41.21
Prestige Consumer Healthcare (PBH) United States $3.983B 19.75
Perrigo (PRGO) Ireland $3.596B 10.59
Neogen (NEOG) United States $3.517B 40.57
Envista Holdings (NVST) United States $3.509B 26.14
Agios Pharmaceuticals (AGIO) United States $3.368B 0.00
GN Store Nord (GNNDY) Denmark $3.041B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.942B 18.94
LeMaitre Vascular (LMAT) United States $2.342B 56.97
Warby Parker (WRBY) United States $1.964B 0.00
Green Thumb Industries (GTBIF) United States $1.888B 33.04
AtriCure (ATRC) United States $1.826B 0.00
InMode (INMD) Israel $1.630B 9.80
Curaleaf Holdings (CURLF) Canada $1.384B 0.00
AdaptHealth (AHCO) United States $1.357B 9.70
Maravai LifeSciences Holdings (MRVI) United States $1.280B 0.00
BioLife Solutions (BLFS) United States $1.206B 0.00
Owens & Minor (OMI) United States $0.995B 7.77
Phibro Animal Health (PAHC) United States $0.966B 17.04
CeriBell (CBLL) United States $0.962B 0.00
National Vision Holdings (EYE) United States $0.906B 30.29
Capricor Therapeutics (CAPR) United States $0.895B 0.00
Evolus (EOLS) United States $0.866B 0.00
Verano Holdings (VRNOF) United States $0.691B 0.00
Cresco Labs (CRLBF) United States $0.605B 0.00
VAREX IMAGING (VREX) United States $0.582B 17.56
Quanterix (QTRX) United States $0.580B 0.00
Surmodics (SRDX) United States $0.549B 0.00
Valneva SE (VALN) France $0.426B 0.00
Canopy Growth (CGC) Canada $0.398B 0.00
ZimVie (ZIMV) United States $0.393B 33.12
Viemed Healthcare (VMD) United States $0.353B 33.59
Cerus (CERS) United States $0.331B 0.00
OraSure Technologies (OSUR) United States $0.320B 21.45
Sanara MedTech (SMTI) United States $0.308B 0.00
Biote (BTMD) United States $0.301B 13.90
Zynex (ZYXI) United States $0.287B 60.07
Jin Medical (ZJYL) China $0.284B 0.00
MacroGenics (MGNX) United States $0.273B 0.00
TerrAscend (TSNDF) Canada $0.269B 0.00
Aurora Cannabis (ACB) Canada $0.264B 0.00
Omeros (OMER) United States $0.256B 0.00
Utah Medical Products (UTMD) United States $0.236B 15.90
High Tide (HITI) Canada $0.221B 91.67
Brainsway (BWAY) Israel $0.181B 217.20
Organigram Holdings (OGI) Canada $0.172B 0.00
FitLife Brands (FTLF) United States $0.151B 20.39
Rockwell Medical (RMTI) United States $0.137B 0.00
TriSalus Life Sciences (TLSI) United States $0.129B 0.00
Quipt Home Medical (QIPT) United States $0.116B 0.00
Zevia PBC (ZVIA) United States $0.111B 0.00
Veru (VERU) United States $0.107B 0.00
Ayr Wellness (AYRWF) United States $0.104B 0.00
Fonar (FONR) United States $0.095B 9.82
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.10
Cellectar Biosciences (CLRB) United States $0.086B 0.00
Sanuwave Health (SNWVD) United States $0.079B 2.67
Modular Medical (MODD) United States $0.072B 0.00
InterCure (INCR) Israel $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
MariMed (MRMD) United States $0.062B 0.00
Safety Shot (SHOT) United States $0.062B 0.00
Apyx Medical (APYX) United States $0.053B 0.00
Exagen (XGN) United States $0.050B 0.00
Allurion Technologies (ALUR) United States $0.048B 0.00
Cytosorbents (CTSO) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
Nephros (NEPH) United States $0.017B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
GlucoTrack (GCTK) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 14.20
SNDL (SNDL) Canada $0.000B 0.00